Zydus Cadila's drug Virafin has got approval from DCGI in the treatment of moderate cases of Coronavirus.
Listen in: Samir Desai, President - BU Biologics, Zydus Group, details the product.
I asked my Guru, “What kind of people should I have around me?”
He answered, “Your circle must have people who inspire you otherwise you don’t have a circle, but a cage.”
#FridayMotivation
#FILA2021 In @ZydusUniverse, Sharvil Patel has an efficient legacy business with the possibility of new drug discovery becoming a significant growth lever. And Patel is a leader on a mission, @_SamarS writes https://t.co/AfTETG93nS